Ashish Kyal of wavesstrategy.com suggests buying Jubilant Life Sciences with a target of Rs 470.
first published: Oct 23, 2015 09:00 am
A collection of the most-viewed Moneycontrol videos.

Live: Will Nifty's weakness continue for the second straight day? | Opening Bell

A money superpower you have in your 20s, not in 40s

Live: Nifty snaps 3-day gaining streak, slips below 26,300 on Venezuela tensions | Closing Bell

Live: Will US-Venezuela tensions derail Nifty's upmove? | Oil stocks in focus | Opening Bell
You are already a Moneycontrol Pro user.

